F-Labeled Radiotracers for Prostate-specific Membrane Antigen: Historical Perspective and Future Directions.

Steven P Rowe, Ali Salavati, Rudolf A Werner, Kenneth J Pienta, Michael A Gorin, Martin G Pomper, Lilja B Solnes

Journal: PET clinics 2022;17(4):585-593

PMID: 36229102

Full Text on Elsevier Science View on PubMed

Abstract

Much of the modern growth in nuclear medicine has been driven by PET imaging of prostate-specific membrane antigen (PSMA) in men with prostate cancer. Fluorine-18 is the ideal PET radionuclide with a moderately long half-life, high positron yield, low positron energy, and cyclotron-based production. F-DCFPyL is the first Food and Drug Administration-approved compound in this class. In this review, we cover a number of aspects of radiofluorinated PSMA PET agents, including their historical development, the early clinical trials, key multicenter registration trials, emerging clinical agents, new compounds that are entering human use, and future directions for the field.

Address: The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA. Electronic address: [email protected].; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA.; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA; Department of Nuclear Medicine, Wuerzburg University Hospital, Oberduerrbacher Street 6, 97080 Wuerzburg, Germany.; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA.; Milton and Carroll Petrie Department of Urology, Icahn School of Medicine at Mount Sinai, 1 Gustave L. Levy Place, Box 1272, New York, NY 10029, USA.; The Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA; The James Buchanan Brady Urological Institute and Department of Urology, Johns Hopkins University School of Medicine, 601 North Caroline Street, Baltimore, MD 21287, USA.

DOI: 10.1016/j.cpet.2022.07.003

Link outs

Free resources

Medical:

https://medlineplus.gov/prostatecancer.html

Miscellaneous:

https://assays.cancer.gov/CPTAC-1491

Subscription / membership required

Full Text Sources:

MeSH Terms: Fluorine Radioisotopes, Humans, Male, Multicenter Studies as Topic, Positron Emission Tomography Computed Tomography, Prostate, Prostate-Specific Antigen, Prostatic Neoplasms